UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 9, 2004
Smith & Wesson Holding Corporation
NEVADA | 001-31552 | 87-0543688 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
2100 ROOSEVELT AVENUE
SPRINGFIELD, MASSACHUSETTS
01104
(800) 331-0852
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition | ||||||||
Item 9.01. Financial Statements and Exhibits | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Item 2.02. Results of Operations and Financial Condition.
The registrant is furnishing this Report on Form 8-K in connection with the disclosure of information, in the form of the textual information from a press release released on December 9, 2004.
The information in this Report on Form 8-K (including the exhibit) is furnished pursuant to Item 2.02 and shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section.
The registrant does not have, and expressly disclaims, any obligation to release publicly any updates or any changes in the registrants expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.
The text included with this Report is available on the registrants website located at www.smith-wesson.com, although the registrant reserves the right to discontinue that availability at any time.
Item 9.01. Financial Statements and Exhibits.
(a) | Financial Statements of Business Acquired. | |||
Not applicable. | ||||
(b) | Pro Forma Financial Information. | |||
Not applicable. | ||||
(c) | Exhibits. |
Exhibit | ||
Number |
Exhibits |
|
99.1
|
Press release from Smith & Wesson Holding Corporation, dated December 9, 2004, entitled Smith & Wesson Reports Second Quarter Earnings Increase |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SMITH & WESSON HOLDING CORPORATION | ||||
Date: December 9, 2004
|
By: | /s/ John A. Kelly
|
||
John A. Kelly | ||||
Chief Financial Officer and Treasurer |
EXHIBIT INDEX
99.1 | Press release from Smith & Wesson Holding Corporation, dated December 9, 2004, entitled Smith & Wesson Reports Second Quarter Earnings Increase |
EXHIBIT 99.1
Contacts:
Smith & Wesson Holding Corporation
John A. Kelly, 413-747-3305
PRESS RELEASE
Smith & Wesson Reports Second Quarter Earnings Increase
SPRINGFIELD, MA (December 9, 2004) Smith & Wesson Holding Corporation (AMEX:SWB), announced today that net income for the three months ended October 31, 2004 was $2.2 million, or $0.07 per diluted share, compared with net income of approximately $671,000, or $0.02 per diluted share, for the three months ended October 31, 2003. Net product sales for the second quarter were $29.1 million, a slight increase over net product sales of $28.9 million for the quarter ended October 31, 2003.
Net income for the six months ended October 31, 2004 was $3.7 million, or $0.11 per diluted share, compared with net income of $1.3 million, or $0.03 per diluted share, for the six months ended October 31, 2003. Net product sales for the six months ended October 31, 2004 were $56.8 million, an $820,100, or 1.4%, decrease from net product sales for the six months ended October 31, 2003.
Firearms sales, the Companys core business, were $26.4 million for the quarter, an increase of $1.8 million, or 7.4%, versus the comparable quarter last year. Non-firearms sales were $2.6 million, a decline of $1.6 million. Firearms sales for the six months ended October 31, 2004 were $51.8 million, a $2.4 million, or 4.8%, increase over the six months ended October 31, 2003. Non-firearms sales for the six-month period were $5.1 million, down $3.2 million, or 38.5%, from the previous year. Non-firearms sales were lower in both the three- and six-month periods as a result of lower handcuff sales and the discontinued optics and third-party machining businesses.
The substantial increase in net income in the second quarter was attributable to an agreement reached with one of the Companys insurance carriers regarding municipal litigation costs. The carrier agreed to reimburse the Company for certain past litigation costs incurred by the Company and agreed to pay a portion of ongoing costs. As a result of the settlement, the profit for the second quarter includes the net refund of $2.0 million and an additional increase in insurance receivables of $2.1 million to reflect the agreement to pay ongoing costs for which the Company has previously provided reserves. Earnings for the quarter were adversely impacted by a provision for severance costs for the Companys former CEO and recruiting costs for his replacement. The total of the severance and recruiting costs was $626,000. These items, after consideration of profit sharing, had an after-tax impact of approximately $1.8 million, or $0.05 per diluted share.
John Kelly, CFO of Smith & Wesson Holding Corporation, said, Firearms sales were up for the quarter as we continue to grow the core business. We experienced some production difficulties in the second quarter that had an adverse impact on sales and profits. Those problems have been corrected as additional capacity will be coming on line in the next quarter.
For the six months ended October 31, 2004, the Company had a cash outflow of $1.1 million, compared with an outflow of $1.7 million for the six months ended October 31, 2003. The cash flow for the six months included $2.0 million in repayment of existing debt, compared with $1.0 million for the six months ended October 31, 2003. Cash flow from operating activities was $2.0 million for the six months ended October 31, 2004, as compared with $1.1 million for the six months ended October 31, 2003.
Outlook for the Remainder of Fiscal Year 2005
In July of this year, the Company retained Merriman, Curhan, Ford & Company to assist in the restructuring of its existing debt. The Company noted that its current debt structure contains restrictive covenants that are no longer consistent with its growth plans. The Company has received proposals from a number of financial institutions and is now in final negotiations on a $40 million credit facility. Upon completion of the restructuring, the Company expects to reduce significantly its outstanding debt through utilization of the cash currently collateralizing the existing debt. The Company also expects interest costs to decrease by over $1.5 million on an annual basis as a result of the lower debt level and a lower interest rate than is currently being paid by the Company. The Company expects to complete the debt restructuring by the end of December.
The Company currently expects sales for the fiscal year ending April 30, 2005 to increase by approximately 5% over the $117.9 million reported for the fiscal year ended April 30, 2004. The Company continues to expect net income to be in the range of $5.4 million to $6.4 million, or between $0.16 and $0.19 per diluted share, compared with $1.4 million, or $0.04 per diluted share, for the fiscal year ended April 30, 2004.
Commenting on the annual projections, John Kelly said, The decline in the dollar has increased the cost of our Walther imports, which accounts for about 10% of our sales. Thus, we will be forced to increase prices on our Walther products in the second half in order to maintain acceptable margins. As a result of the increased prices, we are forecasting a decline in Walther sales in the remainder of the fiscal year. Despite that reduction in sales, our profit projections for the year are unchanged because we expect the results of the insurance agreement will offset the lost profits from the lower sales and the one-time severance and recruiting costs that we have incurred this year.
About Smith & Wesson
Smith & Wesson Holding Corporation is the parent company of Smith & Wesson Corp., one of the worlds leading producers of quality handguns, law enforcement products and firearm safety and security products. Law enforcement personnel, military personnel, target shooters, hunters, collectors, and firearms enthusiasts throughout the world have used the Companys products with confidence for more than 150 years. Smith & Wesson Corp. also manufactures and markets Smith & Wesson branded handcuffs. For more information, visit http://www.smith-wesson.com.
Safe Harbor Statement
Certain statements contained in this press release may be deemed to be
forward-looking statements under federal securities laws, and the Company
intends that such forward-looking statements be subject to the safe-harbor
created thereby. Such forward-looking statements include statements regarding
the Companys sales and earnings projections for the fiscal year ending April
30, 2005, the Companys debt restructuring efforts, future interest rate
savings, the Companys strategies, and the demand for the Companys products,
especially the Walther imports. The Company cautions that these statements are
qualified by important factors that could cause actual results to differ
materially from those reflected by such forward-looking statements. Such
factors include the demand for the Companys products, the Companys growth
opportunities, the ability of the Company to obtain operational enhancements,
the ability of the Company to increase its production capacity, the ability of
the Company to engage additional key employees, and other risks detailed from
time to time in the Companys reports filed with the SEC.
SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED UNAUDITED STATEMENTS OF OPERATIONS
AND OTHER COMPREHENSIVE INCOME
Three months ended |
Six months ended |
|||||||||||||||
October 31, 2004 |
October 31, 2003 |
October 31, 2004 |
October 31, 2003 |
|||||||||||||
Net product sales |
$ | 29,078,039 | $ | 28,874,158 | $ | 56,846,914 | $ | 57,667,014 | ||||||||
License revenue |
526,018 | 362,701 | 922,768 | 786,004 | ||||||||||||
Cost of goods sold |
19,178,562 | 19,808,888 | 37,950,629 | 40,070,608 | ||||||||||||
Cost of services |
4,663 | 57,496 | 33,821 | 57,496 | ||||||||||||
Gross profit |
10,420,832 | 9,370,475 | 19,785,232 | 18,324,914 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research and development, net |
38,184 | 169,145 | 75,323 | 497,763 | ||||||||||||
Selling and marketing |
3,160,186 | 3,319,079 | 6,021,436 | 6,275,980 | ||||||||||||
General and administrative |
4,799,717 | 4,580,365 | 8,400,258 | 7,900,073 | ||||||||||||
Total operating expenses |
7,998,087 | 8,068,589 | 14,497,017 | 14,673,816 | ||||||||||||
Income from operations |
2,422,745 | 1,301,886 | 5,288,215 | 3,651,098 | ||||||||||||
Other income/(expense): |
||||||||||||||||
Other income/(expense) |
1,860,313 | 494,836 | 2,175,306 | (184,784 | ) | |||||||||||
Interest income |
101,049 | 73,225 | 183,299 | 169,896 | ||||||||||||
Interest expense |
(819,261 | ) | (827,499 | ) | (1,654,638 | ) | (1,679,312 | ) | ||||||||
1,142,101 | (259,438 | ) | 703,967 | (1,694,200 | ) | |||||||||||
Income before income taxes |
3,564,846 | 1,042,448 | 5,992,182 | 1,956,898 | ||||||||||||
Income tax expense |
1,321,639 | 371,783 | 2,256,329 | 700,985 | ||||||||||||
Net income |
$ | 2,243,207 | $ | 670,665 | $ | 3,735,853 | $ | 1,255,913 | ||||||||
Other comprehensive income: |
||||||||||||||||
Unrealized gain on marketable
securities |
| 15,738 | | 3,465 | ||||||||||||
Comprehensive income |
$ | 2,243,207 | $ | 686,403 | $ | 3,735,853 | $ | 1,259,378 | ||||||||
Weighted average number of
common equivalent shares
outstanding, basic |
31,279,739 | 30,673,786 | 31,144,761 | 30,647,088 | ||||||||||||
Net income per share, basic |
$ | 0.07 | $ | 0.02 | $ | 0.12 | $ | 0.04 | ||||||||
Weighted average number of
common equivalent shares
outstanding, diluted |
34,381,103 | 37,126,451 | 34,215,049 | 37,098,420 | ||||||||||||
Net income
per share, diluted |
$ | 0.07 | $ | 0.02 | $ | 0.11 | $ | 0.03 | ||||||||
SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED BALANCE SHEETS
As of:
October 31, 2004 | ||||||||
Unaudited |
April 30, 2004 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 4,391,418 | $ | 5,510,663 | ||||
Marketable securities |
| 1,538,738 | ||||||
Accounts receivable, net of allowance for doubtful
accounts of $104,830 on October 31, 2004 and $100,000 on April 30, 2004 |
14,927,941 | 20,249,858 | ||||||
Inventories |
17,480,834 | 15,986,705 | ||||||
Other current assets |
4,711,028 | 1,823,181 | ||||||
Deferred income taxes |
3,935,099 | 3,900,480 | ||||||
Income tax receivable |
160,914 | 160,596 | ||||||
Total current assets |
45,607,234 | 49,170,221 | ||||||
Property, plant, and equipment, net |
13,835,601 | 11,021,174 | ||||||
Intangibles, net |
323,118 | 351,908 | ||||||
Collateralized cash deposits |
22,349,528 | 22,673,059 | ||||||
Notes receivable |
1,051,404 | 1,072,359 | ||||||
Deferred income taxes |
7,544,851 | 9,607,287 | ||||||
Other assets |
6,049,009 | 7,379,099 | ||||||
$ | 96,760,745 | $ | 101,275,107 | |||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 8,580,103 | $ | 9,608,975 | ||||
Accrued expenses |
7,937,174 | 8,335,196 | ||||||
Accrued payroll |
3,015,608 | 3,920,426 | ||||||
Accrued taxes other than income |
1,049,116 | 1,055,506 | ||||||
Accrued profit sharing |
1,577,879 | 2,272,030 | ||||||
Deferred revenue |
34,889 | 442,291 | ||||||
Current portion of notes payable |
4,206,744 | 4,039,456 | ||||||
Total current liabilities |
26,401,513 | 29,673,880 | ||||||
Notes payable |
35,725,062 | 37,870,046 | ||||||
Other non-current liabilities |
13,400,626 | 16,913,947 | ||||||
Commitments and contingencies |
||||||||
Stockholders equity: |
||||||||
Common stock, $.001 par value,
100,000,000 shares authorized, 31,499,193 shares
on October 31, 2004 and 30,935,799 shares on
April 30, 2004 issued and outstanding |
31,499 | 30,936 | ||||||
Additional paid-in capital |
17,352,073 | 16,651,934 | ||||||
Retained earnings |
3,849,972 | 114,119 | ||||||
Accumulated other comprehensive income |
| 20,245 | ||||||
Total stockholders equity |
21,233,544 | 16,817,234 | ||||||
$ | 96,760,745 | $ | 101,275,107 | |||||
SMITH & WESSON HOLDING CORPORATION and Subsidiaries
CONSOLIDATED UNAUDITED STATEMENTS OF CASH FLOWS
For the Six Months Ended:
October 31, 2004 |
October 31, 2003 |
|||||||
Cash flows provided by (used
for) operating activities: |
||||||||
Net income |
$ | 3,735,853 | $ | 1,255,913 | ||||
Adjustments to reconcile net income to
cash provided by (used for) operating activities: |
||||||||
Amortization and depreciation |
1,095,054 | 741,073 | ||||||
Gain on disposal of product line |
(450,515 | ) | | |||||
Gain on sale of assets |
(7,405 | ) | (8,307 | ) | ||||
Write-off of patents |
39,741 | | ||||||
Provision for losses on accounts receivable |
6,500 | 15,300 | ||||||
Provision for excess and obsolete inventory |
385,713 | 375,865 | ||||||
Stock compensation for services |
| 10,000 | ||||||
Changes in operating assets and liabilities: |
||||||||
(Increase) decrease in assets: |
||||||||
Accounts receivable |
5,315,417 | (244,542 | ) | |||||
Inventories |
(1,879,842 | ) | (576,787 | ) | ||||
Other current assets |
(2,887,847 | ) | 763,085 | |||||
Deferred taxes |
2,129,028 | 612,398 | ||||||
Income tax receivable |
(318 | ) | 40,670 | |||||
Note receivable |
20,955 | (129,906 | ) | |||||
Other assets |
1,330,090 | 3,749,779 | ||||||
Increase (decrease) in liabilities: |
||||||||
Accounts payable |
(1,028,872 | ) | (1,872,746 | ) | ||||
Accrued payroll |
(904,818 | ) | 99,989 | |||||
Accrued profit sharing |
(694,151 | ) | 1,176,901 | |||||
Accrued taxes other than income |
(6,390 | ) | 145,340 | |||||
Accrued expenses |
(398,022 | ) | 66,231 | |||||
Other non-current liabilities |
(3,513,321 | ) | (5,114,044 | ) | ||||
Deferred revenue |
(256,887 | ) | (31,539 | ) | ||||
Net cash provided by operating activities |
2,029,963 | 1,074,673 | ||||||
Cash flows (used for) investing activities: |
||||||||
Payments to acquire marketable securities |
| (15,775 | ) | |||||
Proceeds from sale of marketable securities |
1,518,493 | | ||||||
Reduction to collateralized cash deposits |
323,531 | 140,033 | ||||||
Payments to acquire patents |
(17,306 | ) | (13,862 | ) | ||||
Proceeds from sale of property and equipment |
7,465 | 11,209 | ||||||
Proceeds from sale of product line |
300,000 | | ||||||
Payments to acquire property and equipment |
(3,903,186 | ) | (2,083,982 | ) | ||||
Net cash used for investing activities |
(1,771,003 | ) | (1,962,377 | ) | ||||
Cash flows (used for) financing activities: |
||||||||
Payment on notes payable, Tomkins |
(1,417,782 | ) | (1,000,000 | ) | ||||
Proceeds from sale of common stock |
123,307 | 133,593 | ||||||
Proceeds from exercise of
options to acquire common stock |
476,184 | 28,700 | ||||||
Payments on loans and notes payable, unrelated parties |
(559,914 | ) | | |||||
Net cash used for financing activities |
(1,378,205 | ) | (837,707 | ) | ||||
Net decrease in cash
and cash equivalents |
(1,119,245 | ) | (1,725,411 | ) | ||||
Cash and cash equivalents, beginning of year |
5,510,663 | 12,182,010 | ||||||
Cash and cash equivalents, end of period |
$ | 4,391,418 | $ | 10,456,599 | ||||